How could iQor's solutions for operational friction affect hospital operations?
iQor's solutions may help hospitals reduce financial strain from claim denials iQor offers healthcare customer experience programs designed to resolve operational friction, such as prior authorization backlogs and claim denials, which are currently straining healthcare organizations' margins. By using agentic automation and real-time interaction analytics, iQor helps providers identify workflow problems upstream. This capability is relevant because hospitals have spent an estimated $43 billion trying to collect insurer payments for care delivered in 2025, including nearly $18 billion dedicated solely to overturning claim denials. By reducing these avoidable contacts and resolving complex needs, iQor aims to protect revenue for providers.
- Effect
- Mild positive
- How direct
- Brind's reasoning
- When
- Within weeks
- The story
- No new developments lately
How it reaches hospital
-
iQor stated that its customer experience programs assist providers, payers, and life sciences companies in resolving operational friction related to access and authorization delays. These challenges include staffing shortages, claim denials, and enrollment volatility, which are straining healthcare organizations' margins and patient experience.
The full event1independent outlet -
As a provider of customer experience solutions, iQor supports healthcare organizations, including hospitals, by identifying recurring issues in eligibility, authorization, claims, scheduling, and billing. This helps clients reduce the downstream volume of issues, which is currently straining healthcare organizations' margins.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
health care facility
Everything about hospital
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Hospitals spent an estimated $43 billion trying to collect insurer payments for care already delivered in 2025.manilatimes.net
- Nearly $18 billion of that collection effort was spent to overturn claim denials.manilatimes.net
- iQor's healthcare programs have achieved 96% of client key performance indicators.manilatimes.net
- iQor supports 29 healthcare clients across providers, payers and life sciences organizations.manilatimes.net
Why it matters
The financial strain on hospitals is significant, as evidenced by the $43 billion spent on collections and $18 billion dedicated to overturning denials in 2025. These operational challenges, including staffing shortages and authorization backlogs, are actively straining healthcare organizations' margins and patient experience alike. The ability to reduce these costly, avoidable contacts could directly improve a hospital's financial health and operational efficiency.
This issue is part of a broader industry trend where healthcare organizations are contending with mounting cost and compliance pressure. This pressure is compounded by external factors, such as ACA Marketplace insurers proposing a median 18% premium increase for 2026, and increased Medicaid eligibility redetermination beginning in 2027.
What we don't know yet
- What percentage of hospitals currently utilize iQor's specific CX programs?
- How quickly can a hospital realize a measurable reduction in claim denial costs after implementing such solutions?
Is this still moving?
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
What would change this answer
— Other considerations
Beyond this explainer
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Who else could feel it
Other possible ripples from the same event.
Reporting
- manilatimes.netWednesday
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.